Efficacy and safety of low‐dose imatinib in an elderly patient with mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR‐ABL1

Autor:	Ryosuke Yamamura, Yotaro Fujitani, Akiko Miura, Taku Araki, Mirei Horiuchi, Teruhito Takakuwa, Ippei Otomaru, Yusuke Okayama
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	Oncology Drug Medicine (General) medicine.medical_specialty media_common.quotation_subject Ph+MPAL Case Report Case Reports 030204 cardiovascular system & hematology elderly Interstitial pneumonitis 03 medical and health sciences Bcr abl1 R5-920 0302 clinical medicine Internal medicine hemic and lymphatic diseases interstitial pneumonitis mental disorders medicine dasatinib Elderly patient media_common Mixed phenotype acute leukemia business.industry Low dose Imatinib General Medicine humanities Dasatinib imatinib 030220 oncology & carcinogenesis Medicine business medicine.drug
Zdroj:	Clinical Case Reports Clinical Case Reports, Vol 9, Iss 5, Pp n/a-n/a (2021)
ISSN:	2050-0904
Popis:	Low‐dose imatinib with monitoring of drug concentrations in blood may successfully control Philadelphia chromosome‐positive mixed phenotype acute leukemia (Ph+MPAL), particularly in elderly patients with comorbidities.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13fca4c29acfa6907246ea9cd325808 http://europepmc.org/articles/PMC8123726 Zobrazit plný text záznamu Plný text